Search

Your search keyword '"Dao, Fanny"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Dao, Fanny" Remove constraint Author: "Dao, Fanny" Language english Remove constraint Language: english
45 results on '"Dao, Fanny"'

Search Results

1. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

4. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

5. A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

10. Integrated genomic and molecular characterization of cervical cancer

11. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

12. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

19. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

20. Integrated genomic characterization of endometrial carcinoma

23. Integrated Molecular Characterization of Uterine Carcinosarcoma

24. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

25. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

26. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.

27. BRAF Mutation is Associated with Early Stage Disease and Improved Outcome in Patients with Low-Grade Serous Ovarian Cancer

28. Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.

29. Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.

30. Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC).

33. Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual...

34. The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma.

35. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

36. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

37. Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant.

38. Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?

39. Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.

40. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

41. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

42. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

43. Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.

44. Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.

45. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.

Catalog

Books, media, physical & digital resources